Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc.

Core Viewpoint - Stryker is initiating a cash tender offer to acquire all outstanding shares of Inari Medical for $80.00 per share, following a merger agreement dated January 6, 2025 [1][2]. Group 1: Tender Offer Details - The tender offer will expire on February 18, 2025, unless extended [2]. - The offer is contingent upon a minimum tender of a majority of Inari's shares and the expiration of the Hart-Scott-Rodino Antitrust Improvements Act waiting period [2]. - The transaction is expected to close by the end of Q1 2025 [2]. Group 2: Regulatory Filings - Stryker has filed a tender offer statement with the SEC, detailing the terms of the offer [3]. - Inari's Board of Directors has recommended that its stockholders accept the tender offer [3]. Group 3: Company Profiles - Stryker is a global leader in medical technologies, impacting over 150 million patients annually with innovative products in various medical fields [4]. - Inari Medical focuses on creating innovative solutions for unmet health needs, aiming to establish its treatments as the standard of care for specific medical conditions [5].